Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

3.8K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

12.3K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.3K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

6.5K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.5K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

2.2K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.2K
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

5.2K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.2K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NSUN2/m5C/TPI1 axis promotes glycolysis and immune evasion in breast cancer.

Journal of translational medicine·2026
Same author

Efficacy and Safety of Oral NEPA Versus Fosaprepitant Plus Palonosetron for Preventing Chemotherapy-Induced Nausea and Vomiting in Patients with Nasopharyngeal Carcinoma: A Propensity-Score-Matched Retrospective Study.

Cancers·2026
Same author

Photoinduced Radical Alkylation of Cyclic Aldimines with Unactivated C(sp<sup>3</sup>)-H Alcohols Enabled by Alcohol-Directed 1,5-Hydrogen Atom Transfer.

The Journal of organic chemistry·2026
Same author

Implications of LINC01094 for human malignancies.

PeerJ·2026
Same author

Exploiting B7-H3: Molecular Insights and Immunotherapeutic Strategies for Osteosarcoma.

Bioengineering (Basel, Switzerland)·2025
Same author

Cobalt(III)-Catalyzed Selective β-C(sp<sup>2</sup>)-H Alkynylation of Acyclic Enamides with Bromoalkynes.

Organic letters·2025
Same journal

Mesenchymal stem cells-derived extracellular vesicles as a novel drug delivery carrier: engineering strategies and clinical safety estimation.

Frontiers in molecular biosciences·2026
Same journal

Preparation and analysis of tobacco glycosides, and the relationship between glycoside aglycones and pyrolysis products: a review.

Frontiers in molecular biosciences·2026
Same journal

Peritoneal metastasis in pancreatic cancer: molecular mechanisms, microenvironmental remodeling, and emerging intraperitoneal interventions.

Frontiers in molecular biosciences·2026
Same journal

Insights from LC-MS-based cerebrospinal fluid metabolomics in tuberculous meningitis.

Frontiers in molecular biosciences·2026
Same journal

Emerging roles of Notch signaling in the tumor microenvironment of digestive system cancers.

Frontiers in molecular biosciences·2026
Same journal

Adenosine metabolism as an endogenous protective mechanism in response to upstream ischemic injury.

Frontiers in molecular biosciences·2026
See all related articles

Related Experiment Video

Updated: Aug 25, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

467

Insights from DOCK2 in cell function and pathophysiology.

Lulin Ji1, Shuquan Xu2, Haiqing Luo3,4

  • 1The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute and School of Basic Medical Sciences, Central South University, Changsha, China.

Frontiers in Molecular Biosciences
|October 17, 2022
PubMed
Summary
This summary is machine-generated.

Dedicator of cytokinesis 2 (DOCK2) regulates immune cell functions and cytoskeletal organization. This review highlights DOCK2

Keywords:
ROScancerdockinflammatory responsemigration

More Related Videos

Real-Time Impedance-based Cell Analyzer as a Tool to Delineate Molecular Pathways Involved in Neurotoxicity and Neuroprotection in a Neuronal Cell Line
08:23

Real-Time Impedance-based Cell Analyzer as a Tool to Delineate Molecular Pathways Involved in Neurotoxicity and Neuroprotection in a Neuronal Cell Line

Published on: August 9, 2014

11.5K
Canine Intestinal Organoids in a Dual-Chamber Permeable Support System
11:11

Canine Intestinal Organoids in a Dual-Chamber Permeable Support System

Published on: March 2, 2022

3.8K

Related Experiment Videos

Last Updated: Aug 25, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

467
Real-Time Impedance-based Cell Analyzer as a Tool to Delineate Molecular Pathways Involved in Neurotoxicity and Neuroprotection in a Neuronal Cell Line
08:23

Real-Time Impedance-based Cell Analyzer as a Tool to Delineate Molecular Pathways Involved in Neurotoxicity and Neuroprotection in a Neuronal Cell Line

Published on: August 9, 2014

11.5K
Canine Intestinal Organoids in a Dual-Chamber Permeable Support System
11:11

Canine Intestinal Organoids in a Dual-Chamber Permeable Support System

Published on: March 2, 2022

3.8K

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Dedicator of cytokinesis 2 (DOCK2) is crucial for immune cell migration, activation, and proliferation.
  • DOCK2 influences T and B lymphocyte development and function, including synapse formation and Th2 lineage inhibition.
  • DOCK2 defects impair lymphocyte chemotaxis and neutrophil reactive oxygen species (ROS) production.

Purpose of the Study:

  • To review recent advances in DOCK2 function within various immune cells.
  • To explore the multifaceted role of DOCK2 in the pathogenesis of diverse diseases.
  • To elucidate DOCK2's impact on inflammatory responses and disease progression.

Main Methods:

  • Literature review of studies on DOCK2 function and disease association.
  • Analysis of DOCK2's molecular mechanisms in immune cell regulation.
  • Synthesis of findings regarding DOCK2's involvement in conditions like Alzheimer's disease, transplant rejection, and inflammatory disorders.

Main Results:

  • DOCK2 modulates cytoskeletal dynamics via Rac activation, essential for immune cell activities.
  • DOCK2 plays distinct roles in various immune cells, impacting T cell differentiation and B cell activation.
  • DOCK2 is implicated in Alzheimer's disease, cardiac transplant rejection, and inflammatory conditions, with varying effects on disease severity.

Conclusions:

  • DOCK2 is a key regulator of immune cell function and a potential therapeutic target for immune-related diseases.
  • Understanding DOCK2's diverse roles is critical for developing targeted treatments for conditions ranging from neurodegenerative disorders to inflammatory diseases.
  • Further research into DOCK2's specific mechanisms in different diseases will illuminate its therapeutic potential.